Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs | Zendy

Michael Mengel | Zendy; M. Marwedel | Zendy; J. Radermacher | Zendy; Gabriele Eden | Zendy; Albin Schwarz | Zendy; Hermann Haller | Zendy; Hans Kreipe | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Incidence of polyomavirus-nephropathy in renal allografts: influence of modern immunosuppressive drugs

Author(s) -

Michael Mengel,

M. Marwedel,

J. Radermacher,

Gabriele Eden,

Albin Schwarz,

Hermann Haller,

Hans Kreipe

Publication year - 2003

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfg072

Subject(s) - medicine , incidence (geometry) , nephropathy , urology , immunology , endocrinology , physics , optics , diabetes mellitus

In recent years an increasing number of cases with polyomavirus (PV)-nephropathy after renal transplantation were reported from several transplant centres. New, highly potent immunosuppressive drugs like tacrolimus or mycophenolate mofetil were accused as risk factors for this increase. However, data about the incidence of PV-nephropathy in correlation to different immunosuppressive therapy concepts are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research